WELLS FARGO & COMPANY/MN - REDHILL BIOPHARMA LTD ownership

REDHILL BIOPHARMA LTD's ticker is RDHL and the CUSIP is 757468103. A total of 68 filers reported holding REDHILL BIOPHARMA LTD in Q4 2020. The put-call ratio across all filers is 1.29 and the average weighting 0.1%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of REDHILL BIOPHARMA LTD
ValueSharesWeighting
Q4 2022$272
-72.8%
1,942
-0.1%
0.00%
Q3 2022$1,000
-50.0%
1,9430.0%0.00%
Q2 2022$2,0000.0%1,943
+106.0%
0.00%
Q1 2022$2,000
-71.4%
943
-64.2%
0.00%
Q4 2021$7,000
-99.5%
2,636
-99.1%
0.00%
Q3 2021$1,300,000
-26.8%
283,858
+10.0%
0.00%
Q2 2021$1,776,000
+21.1%
258,018
+28.8%
0.00%
Q1 2021$1,466,000
+34.4%
200,300
+48.4%
0.00%
Q4 2020$1,091,000
-22.2%
134,990
-1.7%
0.00%
Q3 2020$1,403,000
+15488.9%
137,290
+9884.7%
0.00%
Q2 2020$9,000
+125.0%
1,375
+71.9%
0.00%
Q1 2020$4,000
-20.0%
800
-11.3%
0.00%
Q4 2019$5,000
-70.6%
902
-63.2%
0.00%
Q3 2019$17,000
+183.3%
2,452
+171.8%
0.00%
Q2 2019$6,000
-14.3%
9020.0%0.00%
Q1 2019$7,000
+40.0%
9020.0%0.00%
Q4 2018$5,000
-37.5%
9020.0%0.00%
Q3 2018$8,0000.0%9020.0%0.00%
Q2 2018$8,000
+166.7%
902
+59.9%
0.00%
Q1 2018$3,0000.0%5640.0%0.00%
Q4 2017$3,000
-91.4%
564
-82.2%
0.00%
Q3 2017$35,000
+45.8%
3,166
+10.5%
0.00%
Q2 2017$24,000
-11.1%
2,8660.0%0.00%
Q1 2017$27,000
+28.6%
2,866
+42.2%
0.00%
Q4 2016$21,000
-22.2%
2,016
+5.3%
0.00%
Q3 2016$27,000
-18.2%
1,914
-36.2%
0.00%
Q2 2016$33,000
-32.7%
3,000
-25.0%
0.00%
Q1 2016$49,000
-5.8%
4,0000.0%0.00%
Q4 2015$52,0000.0%4,0000.0%0.00%
Q3 2015$52,000
-1.9%
4,000
+33.3%
0.00%
Q2 2015$53,000
-39.8%
3,000
-50.0%
0.00%
Q1 2015$88,000
+120.0%
6,000
+100.0%
0.00%
Q4 2014$40,0000.0%3,0000.0%0.00%
Q3 2014$40,000
-23.1%
3,0000.0%0.00%
Q2 2014$52,000
+23.8%
3,0000.0%0.00%
Q1 2014$42,0003,0000.00%
Other shareholders
REDHILL BIOPHARMA LTD shareholders Q4 2020
NameSharesValueWeighting ↓
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of REDHILL BIOPHARMA LTD shareholders